Eliasson, Björn

Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes

Lim, C.-E., Pasternak, B., Eliasson, B., & Ueda, P. (2025) · Diabetologia

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 27

MANAGEMENT OF ENDOCRINE DISEASE disease burden and treatment challenges in patients with both Addison's disease and type 1 diabetes mellitus

Chantzichristos, D., Eliasson, B., & Johannsson, G. (2020) · European Journal of Endocrinology

Adrenal Hormones and DisordersDiabetes Management and Research

Cited by 21

Treatment Persistence in Patients with Type 2 Diabetes Treated with Glucagon-like Peptide-1 Receptor Agonists in Clinical Practice in Sweden

Svensson, A., Toll, A., Lebrec, J., Miftaraj, M., Franzén, S., & Eliasson, B. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementMedication Adherence and Compliance

Cited by 17

Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study

Chantzichristos, D., Persson, A., Miftaraj, M., Eliasson, B., Svensson, A.-M., & Johannsson, G. (2019) · The Journal of Clinical Endocrinology & Metabolism

Adrenal Hormones and DisordersDiabetes Management and Research

Cited by 9